Raising the bar for using surrogate endpoints in drug regulation and health technology assessment
Surrogate endpoints provide no guarantee of clinical benefit, and Dalia Dawoud and colleagues argue they should be used only as a last resort in drug trials In June 2021, the US Food and Drug...
bmj.com